Evaluation of biomedical industry technological innovation ability based on a grey panel clustering model.

Abstract

Technological innovation in the biomedical industry is the basis for improving the core competitiveness of the biomedical industry and promoting the high-quality development of the industry. However, the technological innovation capacity of China's biomedical industry is not balanced, and there are great differences between regions. Therefore, accurately grasping the status quo of technological innovation in China's biomedical industry and assessing regional differences are of great significance and effect for the country to formulate targeted policies and systems. In view of this, this paper designs a two-stage biomedical industry technological innovation capability evaluation index system from the perspective of the innovation value chain. According to the panel data of China's biomedical industry from 2012 to 2018, a grey relational clustering model based on panel data is constructed and used to evaluate the technological innovation capability of China's biomedicine industry from two dimensions: the level of technological research and development and the ability to transform technological achievements.